CHAPTER 2 PRINCIPLES OF MANAGEMENT



10.1055/b-0037-145003

CHAPTER 2 PRINCIPLES OF MANAGEMENT

Arin K. Greene

KEY POINTS




  • Accurate diagnosis of a vascular anomaly must be confirmed before determining the appropriate management.



  • Treatment of a vascular anomaly may include observation, pharmacotherapy (topical, intralesional, systemic), embolization, sclerotherapy, laser, and/or surgery.



  • Intervention is based on the type of vascular anomaly, symptoms, and the physician’s preference.



  • Patients may require interdisciplinary care and are often best managed by physicians who are focused on vascular anomalies.


The field of vascular anomalies is confusing, because lesions look similar and terminology is difficult. Although some vascular anomalies can be treated by a single physician, many require interdisciplinary care (particularly vascular malformations). Patients generally are best managed in a vascular anomalies center by providers who are focused on these lesions. Several types of treatments are used: embolization, laser, pharmacotherapy (topical, intralesional, and systemic), resection, and sclerotherapy. Often a consensus does not exist about the best intervention, because there is a lack of randomized, prospective evidence. Evaluation of treatments is further handicapped by the heterogeneity of the lesions. For example, one arteriovenous malformation can be small and located on the face, whereas another may involve an entire extremity. The intervention chosen to treat a vascular anomaly is frequently based on retrospective evidence and the preference of the physician.


Principles of management include the following:




  • Patients should be treated by physicians who focus on this field.



  • A correct diagnosis must be confirmed before choosing management.



  • Many lesions can be observed and intervention is not mandatory.



  • The goal of treatment usually is to control rather than to cure the vascular anomaly.



  • Complete resection rarely is required.



  • Surgical intervention should not create a worse deformity than the appearance of the lesion.



VARIABLES THAT DETERMINE MANAGEMENT


Three variables determine how a vascular anomaly is managed:




  1. Diagnosis



  2. Morbidity



  3. Physician preference


















































Table 2-1 Major Vascular Anomalies and Treatments

Tumors


Malformations


Biologic Name


Morbidity


Treatment


Biologic Name


Morbidity


Treatment


Infantile hemangioma


Deformity


Obstruction


Destruction


Ulceration


Observation


Topical timolol


Triamcinolone (Kenalog) injection


Oral prednisolone


Oral propranolol


Pulsed-dye laser


Resection


Capillary malformation


Deformity


Tissue overgrowth


Observation


Pulsed-dye laser


Resection


Congenital hemangioma


Deformity


Observation


Resection


Lymphatic malformation


Deformity


Bleeding


Infection


Pain


Observation


Sclerotherapy


Radiofrequency


Ablation Carbon dioxide laser


Sirolimus


Resection


Kaposiform hemangioendothelioma


Deformity


Thrombocytopenia


Fibrosis


Pain


Vincristine


Sirolimus


Venous malformation


Deformity


Phlebothrombosis


Pain


Observation


Sclerotherapy


Resection


Pyogenic granuloma


Deformity


Bleeding


Cautery


Resection


Arteriovenous malformation


Deformity


Bleeding


Ulceration


Pain


Observation


Embolization


Resection



DIAGNOSIS


The most important determinant of how a vascular anomaly is managed is the patient’s diagnosis. Before a physician treats a vascular anomaly, the lesion must be accurately identified with the correct terminology. At least 90% of vascular anomalies can be diagnosed by history and physical examination; the remainder requires imaging (about 9%) or histopathology (about 1%). Some lesions often do not require treatment (for example, infantile hemangioma, congenital hemangioma, and capillary malformation), whereas others almost always necessitate intervention (for example, kaposiform hemangioendothelioma and pyogenic granuloma). Because most vascular anomalies are asymptomatic at the time of initial diagnosis, treatment is frequently based on the natural history of the lesion. For example, a macrocystic lymphatic malformation is usually treated prophylactically with sclerotherapy, because it is at risk for enlargement, bleeding, and infection. In contrast, an arteriovenous malformation most commonly is managed by observation; embolization and/or resection typically are performed only if the lesion becomes symptomatic.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 26, 2020 | Posted by in Reconstructive surgery | Comments Off on CHAPTER 2 PRINCIPLES OF MANAGEMENT

Full access? Get Clinical Tree

Get Clinical Tree app for offline access